JP2021501596A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021501596A5 JP2021501596A5 JP2020524540A JP2020524540A JP2021501596A5 JP 2021501596 A5 JP2021501596 A5 JP 2021501596A5 JP 2020524540 A JP2020524540 A JP 2020524540A JP 2020524540 A JP2020524540 A JP 2020524540A JP 2021501596 A5 JP2021501596 A5 JP 2021501596A5
- Authority
- JP
- Japan
- Prior art keywords
- expansion
- lymphocytes
- interleukin
- apc
- peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762582163P | 2017-11-06 | 2017-11-06 | |
| US62/582,163 | 2017-11-06 | ||
| PCT/EP2018/080343 WO2019086711A1 (en) | 2017-11-06 | 2018-11-06 | Method for expansion of lymphocytes |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021501596A JP2021501596A (ja) | 2021-01-21 |
| JP2021501596A5 true JP2021501596A5 (cg-RX-API-DMAC7.html) | 2021-10-28 |
| JP7357613B2 JP7357613B2 (ja) | 2023-10-06 |
Family
ID=64332272
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020524540A Active JP7357613B2 (ja) | 2017-11-06 | 2018-11-06 | リンパ球の拡大方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20200338125A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3707245A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7357613B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN111801415A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2018361561C1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3081479A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2019086711A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3877055A1 (en) | 2018-11-05 | 2021-09-15 | Ludwig Institute for Cancer Research Ltd | Humanized and variant tgf-beta1 specific antibodies and methods and uses thereof |
| CA3118027A1 (en) | 2018-11-05 | 2020-05-14 | Ludwig Institute For Cancer Research Ltd. | Humanized and variant tgf-.beta.3 specific antibodies and methods and uses thereof |
| CA3145196A1 (en) * | 2019-06-24 | 2020-12-30 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | A peptide-based screening method to identify neoantigens for use with tumor infiltrating lymphocytes |
| JP7337373B2 (ja) * | 2019-07-29 | 2023-09-04 | サイアス株式会社 | 抗原特異的t細胞の製造方法 |
| CA3161510A1 (en) * | 2019-12-18 | 2021-06-24 | CBio A/S | Improved process for culturing tumor-infiltrating lymphocytes for therapeutic use |
| WO2021222479A1 (en) | 2020-04-28 | 2021-11-04 | Lyell Immunopharma, Inc. | Methods for culturing cells |
| KR20230019460A (ko) * | 2020-05-29 | 2023-02-08 | 상하이 준셀 테라퓨틱스 컴퍼니 리미티드 | 종양 침윤 림프구의 종자세포 배지 및 이의 용도 |
| AU2021320556A1 (en) | 2020-08-07 | 2023-03-09 | Neogene Therapeutics B.V. | Methods to enrich genetically engineered T cells |
| CA3192356A1 (en) * | 2020-08-17 | 2022-02-24 | Northwestern University | B-cell based immunotherapy for the treatment of glioblastoma and other cancers |
| TWI895549B (zh) | 2020-11-19 | 2025-09-01 | 大陸商蘇州沙礫生物科技有限公司 | 腫瘤浸潤淋巴細胞的培養方法及其用途 |
| CN112501308B (zh) * | 2020-11-30 | 2025-10-10 | 中国水产科学研究院珠江水产研究所 | 一组鳖科动物线粒体全基因组扩增通用引物 |
| US20240043801A1 (en) * | 2020-12-24 | 2024-02-08 | Suzhou Grit Biotechnology Co., Ltd. | Preparation method for tumor infiltrating lymphocyte and use thereof |
| CN114686430A (zh) * | 2020-12-31 | 2022-07-01 | 上海赛比曼生物科技有限公司 | 一种制备til的方法 |
| AU2022210312A1 (en) * | 2021-01-20 | 2023-08-31 | Neogene Therapeutics B.V. | Engineered antigen presenting cells |
| CN115315509B (zh) * | 2021-02-08 | 2024-05-07 | 苏州沙砾生物科技有限公司 | 肿瘤浸润淋巴细胞的制备方法及其用途 |
| BR112023022485A2 (pt) * | 2021-04-30 | 2024-01-09 | Centre Hospitalier Univ Vaudois Chuv | Expansão de linfócitos em um único recipiente |
| US20240207319A1 (en) | 2021-05-06 | 2024-06-27 | Ludwig Institute For Cancer Research Ltd | Compositions and methods for immunotherapy |
| KR20240023426A (ko) * | 2021-06-22 | 2024-02-21 | 아킬레스 테라퓨틱스 유케이 리미티드 | 항원-특이적 t 세포를 생산하는 방법 |
| US20240360410A1 (en) * | 2021-08-03 | 2024-10-31 | Suzhou Grit Biotechnology Co., Ltd. | Modified tumor infiltrating lymphocyte and use thereof |
| WO2023049733A2 (en) * | 2021-09-21 | 2023-03-30 | The University Of Chicago | Methods and composition using patient-derived autologous neoantigens for treating cancer |
| CN115433713B (zh) * | 2022-03-03 | 2023-10-27 | 中山大学孙逸仙纪念医院深汕中心医院 | 一种自体肿瘤引流淋巴结淋巴细胞的制备方法及其应用 |
| WO2024261339A1 (en) | 2023-06-23 | 2024-12-26 | Tigen Pharma Sa | Lymphocyte-stimulatory matrix (lsm) and uses thereof for expansion of lymphocyte populations |
| WO2025081198A1 (en) * | 2023-10-13 | 2025-04-17 | Northwestern University | B cell production and expansion |
| WO2025131119A1 (en) * | 2023-12-22 | 2025-06-26 | Everest Medicines (China) Co., Ltd. | Cancer vaccines and uses thereof |
| EP4752217A1 (en) | 2024-11-28 | 2026-06-03 | invIOs GmbH | Manufacturing method for activated lymphocytes |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6905680B2 (en) | 1988-11-23 | 2005-06-14 | Genetics Institute, Inc. | Methods of treating HIV infected subjects |
| US6352694B1 (en) | 1994-06-03 | 2002-03-05 | Genetics Institute, Inc. | Methods for inducing a population of T cells to proliferate using agents which recognize TCR/CD3 and ligands which stimulate an accessory molecule on the surface of the T cells |
| US6534055B1 (en) | 1988-11-23 | 2003-03-18 | Genetics Institute, Inc. | Methods for selectively stimulating proliferation of T cells |
| US5858358A (en) | 1992-04-07 | 1999-01-12 | The United States Of America As Represented By The Secretary Of The Navy | Methods for selectively stimulating proliferation of T cells |
| US7175843B2 (en) | 1994-06-03 | 2007-02-13 | Genetics Institute, Llc | Methods for selectively stimulating proliferation of T cells |
| US7067318B2 (en) | 1995-06-07 | 2006-06-27 | The Regents Of The University Of Michigan | Methods for transfecting T cells |
| US6692964B1 (en) | 1995-05-04 | 2004-02-17 | The United States Of America As Represented By The Secretary Of The Navy | Methods for transfecting T cells |
| US6291430B1 (en) | 1997-09-12 | 2001-09-18 | Ludwig Institute For Cancer Research | Mage-3 peptides presented by HLA class II molecules |
| US6867041B2 (en) | 2000-02-24 | 2005-03-15 | Xcyte Therapies, Inc. | Simultaneous stimulation and concentration of cells |
| HK1052372A1 (zh) | 2000-02-24 | 2003-09-11 | Xcyte Therapies, Inc. | 细胞的同步刺激和富集 |
| US6797514B2 (en) | 2000-02-24 | 2004-09-28 | Xcyte Therapies, Inc. | Simultaneous stimulation and concentration of cells |
| WO2003015757A1 (en) | 2001-08-16 | 2003-02-27 | The Trustees Of The University Of Pennsylvania | Synthesis and use of reagents for improved dna lipofection and/or slow release prodrug and drug therapies |
| US8034334B2 (en) | 2002-09-06 | 2011-10-11 | The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Immunotherapy with in vitro-selected antigen-specific lymphocytes after non-myeloablative lymphodepleting chemotherapy |
| JP5838021B2 (ja) | 2005-04-15 | 2015-12-24 | マクロジェニクス,インコーポレーテッド | 共有結合型ダイアボディとその使用 |
| US9963510B2 (en) | 2005-04-15 | 2018-05-08 | Macrogenics, Inc. | Covalent diabodies and uses thereof |
| EP1995316A1 (de) | 2007-05-25 | 2008-11-26 | Qiagen GmbH | Verfahren zur schonenden Zellaufreinigung, Zellgewinnung und Transfektion von Zellen |
| EP2009095A1 (en) | 2007-06-28 | 2008-12-31 | Innovalor AG | Method of generating glucose-responsive cells |
| US8629098B2 (en) | 2008-01-15 | 2014-01-14 | Yale University | Compositions and methods for adoptive and active immunotherapy |
| CN101824400B (zh) * | 2009-03-05 | 2012-08-08 | 中国科学院微生物研究所 | 一种放大增殖抗原特异性t细胞的方法 |
| US8383099B2 (en) * | 2009-08-28 | 2013-02-26 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Adoptive cell therapy with young T cells |
| US9115402B2 (en) * | 2010-05-14 | 2015-08-25 | Dana-Farber Cancer Institute, Inc. | Compositions and methods of identifying tumor specific neoantigens |
| US10023657B2 (en) | 2010-10-01 | 2018-07-17 | Ludwig Institute For Cancer Research Ltd. | Reversible protein multimers, methods for their production and use |
| BR112014014591A8 (pt) * | 2011-12-12 | 2017-07-04 | Baylor College Medicine | processo para a expansão in vitro de células t específicas de antígeno, produto de células t autólogas ou alogênicas expandidas, composição farmacêutica, e, método de tratamento de um paciente, e, usos de uma linhagem de células engenheirada, de células dendríticas pulsadas com misturas de antígeno-peptídeo, de t-apcs pulsadas com misturas de antígeno-peptídeo/peptídeo, e de misturas de antígeno-peptídeo com pbmcs |
| UA123821C2 (uk) * | 2014-06-11 | 2021-06-09 | Полібіосепт Гмбх | Композиція для експансії лімфоцитів in vitro |
| SG11201702191YA (en) * | 2014-09-17 | 2017-04-27 | Univ Johns Hopkins | Reagents and methods for identifying, enriching, and/or expanding antigen-specific t cells |
| CN107075479A (zh) * | 2014-10-02 | 2017-08-18 | 美国卫生和人力服务部 | 分离对癌症特异性突变具有抗原特异性的t细胞的方法 |
| WO2016145578A1 (en) * | 2015-03-13 | 2016-09-22 | Syz Cell Therapy Co. | Methods of cancer treatment using activated t cells |
| WO2017192924A1 (en) * | 2016-05-04 | 2017-11-09 | Fred Hutchinson Cancer Research Center | Cell-based neoantigen vaccines and uses thereof |
-
2018
- 2018-11-06 CA CA3081479A patent/CA3081479A1/en active Pending
- 2018-11-06 CN CN201880079423.3A patent/CN111801415A/zh active Pending
- 2018-11-06 WO PCT/EP2018/080343 patent/WO2019086711A1/en not_active Ceased
- 2018-11-06 US US16/761,711 patent/US20200338125A1/en active Pending
- 2018-11-06 EP EP18804249.3A patent/EP3707245A1/en active Pending
- 2018-11-06 JP JP2020524540A patent/JP7357613B2/ja active Active
- 2018-11-06 AU AU2018361561A patent/AU2018361561C1/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7391015B2 (ja) | P53がん特異的変異に対して抗原特異性を有するt細胞を単離する方法 | |
| JP2024001069A (ja) | がんを治療するための方法 | |
| CN107206024B (zh) | 改变cart细胞中的基因表达及其用途 | |
| EP3265570B1 (en) | Retroviral and lentiviral vectors | |
| AU2023285735A1 (en) | Methods of isolating T cells having antigenic specificity for a cancer-specific mutation | |
| JP6942059B2 (ja) | クローディン−18.2−特異的免疫受容体およびt細胞エピトープ | |
| JP2022531231A5 (cg-RX-API-DMAC7.html) | ||
| CN112955465A (zh) | 抗tcr抗体分子及其用途 | |
| JP7817937B2 (ja) | 腫瘍反応性t細胞のエクスビボ富化および増大のための方法ならびに関連するその組成物 | |
| US20230265390A1 (en) | Enhanced expansion and cytotoxicity of engineered natural killer cells and uses thereof | |
| CN113677352A (zh) | T细胞修饰 | |
| TW201930591A (zh) | 用於與嵌合抗原受體療法併用之免疫增強rna | |
| TWI334442B (en) | Process for producing cytotoxic lymphocyte | |
| JP2013014587A (ja) | T細胞亜集団に特異的なモノクローナル抗体およびポリクローナル抗体の組成物および使用方法 | |
| JP2017531640A (ja) | がん特異的突然変異に対し抗原特異性を有するt細胞受容体を単離する方法 | |
| CN101243187B (zh) | 淋巴细胞的制备方法 | |
| JP2017533707A (ja) | T細胞を刺激および拡大する組成物および方法 | |
| JP2018511320A (ja) | 治療およびエピトープマッピング用T細胞の感作および増殖のためのin vitro人工リンパ節法 | |
| JP2024050551A (ja) | マウス定常領域を伴うtcrを発現する細胞を選択的に増幅するための方法 | |
| WO2019210207A2 (en) | Chimeric antigen receptor t regulatory cells for the treatment of atherosclerosis | |
| CA3214450A1 (en) | Single vessel expansion of lymphocytes | |
| CN108607094A (zh) | 由基因工程化的人造抗原提呈细胞的分泌小体所构建的t细胞疫苗及其制备方法和应用 | |
| JP2018510644A (ja) | 治療およびエピトープマッピング用T細胞の感作および増殖のためのin vitro人工リンパ節 | |
| CN115991790B (zh) | 一种增强肿瘤抗原作用的car及其应用 | |
| AU2022210312A1 (en) | Engineered antigen presenting cells |